Filing Details
- Accession Number:
- 0001181431-14-008205
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-20 21:18:09
- Reporting Period:
- 2014-02-20
- Filing Date:
- 2014-02-20
- Accepted Time:
- 2014-02-20 21:18:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1179929 | Molina Healthcare Inc | MOH | Hospital & Medical Service Plans (6324) | 134204626 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1305822 | Terry Bayer | 300 University Avenue, Suite 100 Sacramento CA 95825 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-02-20 | 22,815 | $36.95 | 93,276 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | $29.53 | 2015-07-01 | 31,500 | 31,500 | Direct | |
Common Stock | Stock Options (Right to Buy) | $19.11 | 2016-02-02 | 21,000 | 21,000 | Direct | |
Common Stock | Stock Options (Right to Buy) | $20.88 | 2017-03-01 | 16,500 | 16,500 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2015-07-01 | 31,500 | 31,500 | Direct |
2016-02-02 | 21,000 | 21,000 | Direct |
2017-03-01 | 16,500 | 16,500 | Direct |
Footnotes
- Represents the weighted average selling price with respect to four sales, with a selling price range between $36.50 and $37.00.
- 15,572 shares shall vest upon the Company achieving total revenue in any of the 2013, 2014, or 2015 fiscal years equal to or greater than $12 billion; 15,571 shares shall vest upon the Company achieving three-year EBITDA margin for the three-year period ending December 31, 2013 equal to or greater than 2.5%; 10,290 shares vest on March 1, 2014; and 5,191 shares vest on each of March 1, 2015 and March 1, 2016. The remainder of the shares are vested.
- The options are fully vested.